Stay updated with breaking news from Simulations Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts have been eager to weigh in on the Technology sector with new ratings on Health Catalyst (HCAT – Research Report), ForgeRock Inc (FORG...
Simulations Plus, Inc. , a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of a new integrated pulmonary software... | May 10, 2023
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of a new integrated pulmonary software and services package. This targeted package will support pharmaceuti...
The Wall Street firm said this stock is a category leader for model-informed drug development (MIDD), or simulations for biotech drug trials.
Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, April 26th. The stock was sold at an average price of $41.52, for a total transaction of $830,400.00. Following the completion of the transaction, the director now directly owns 3,875,739 shares in […]